Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nouvel Pharm Oy
OY
Active
Y-tunnus 3550707-1
Päätie 36A-362, 00590
Helsinki
Other human health activities n.e.c.
·
NACE 8699
Est. 2025 · 1 year old
1 employees
Share
Finland
/
Companies
/
Other human health activities n.e.c.
/
Nouvel Pharm Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
Revenue
24
Staff expenses
−17
EBITDA
−2
Depreciation & amort.
−0
EBIT
−2
Net financials
−0
Profit before tax
−2
Tax
−5
Net profit
2
Balance sheet
EUR thousands
Item
2025
Total assets
5
Equity
−2
Long-term debt
0
Short-term debt
7
Total debt
7
Financial ratios
5-year trend
EBITDA margin
−9,8 %
This company
15,8 %
Market median
This company
Market median
162% below market
2025
2025
Equity ratio
−48,4 %
This company
38,2 %
Market median
This company
Market median
227% below market
2025
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2025
2025
Net profit margin
10,1 %
This company
8,1 %
Market median
This company
Market median
25% above market
2025
2025
Asset turnover
4,81×
This company
1,12×
Market median
This company
Market median
329% above market
2025
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2025
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-07-13 – 2025-12-31
View
PDF
More on Nouvel Pharm Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
